Literature DB >> 33176162

Poison Exon Splicing Regulates a Coordinated Network of SR Protein Expression during Differentiation and Tumorigenesis.

Nathan K Leclair1, Mattia Brugiolo2, Laura Urbanski1, Shane C Lawson3, Ketan Thakar2, Marina Yurieva2, Joshy George4, John Travis Hinson5, Albert Cheng6, Brenton R Graveley7, Olga Anczuków8.   

Abstract

The RNA isoform repertoire is regulated by splicing factor (SF) expression, and alterations in SF levels are associated with disease. SFs contain ultraconserved poison exon (PE) sequences that exhibit greater identity across species than nearby coding exons, but their physiological role and molecular regulation is incompletely understood. We show that PEs in serine-arginine-rich (SR) proteins, a family of 14 essential SFs, are differentially spliced during induced pluripotent stem cell (iPSC) differentiation and in tumors versus normal tissues. We uncover an extensive cross-regulatory network of SR proteins controlling their expression via alternative splicing coupled to nonsense-mediated decay. We define sequences that regulate PE inclusion and protein expression of the oncogenic SF TRA2β using an RNA-targeting CRISPR screen. We demonstrate location dependency of RS domain activity on regulation of TRA2β-PE using CRISPR artificial SFs. Finally, we develop splice-switching antisense oligonucleotides to reverse the increased skipping of TRA2β-PE detected in breast tumors, altering breast cancer cell viability, proliferation, and migration.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RNA splicing, SR proteins, differentiation, cancer, cross-regulation, antisense oligonucleotides, CRISPR/Cas13, CRISPR-Artificial Splicing Factors, alternative splicing, oncogene

Year:  2020        PMID: 33176162      PMCID: PMC7680420          DOI: 10.1016/j.molcel.2020.10.019

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  15 in total

Review 1.  Alternative splicing as a source of phenotypic diversity.

Authors:  Charlotte J Wright; Christopher W J Smith; Chris D Jiggins
Journal:  Nat Rev Genet       Date:  2022-07-12       Impact factor: 59.581

2.  Dynamics and functional roles of splicing factor autoregulation.

Authors:  Fangyuan Ding; Christina J Su; KeHuan Kuo Edmonds; Guohao Liang; Michael B Elowitz
Journal:  Cell Rep       Date:  2022-06-21       Impact factor: 9.995

Review 3.  Perfect and imperfect views of ultraconserved sequences.

Authors:  Valentina Snetkova; Len A Pennacchio; Axel Visel; Diane E Dickel
Journal:  Nat Rev Genet       Date:  2021-11-11       Impact factor: 59.581

4.  Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.

Authors:  Zixiang Wang; Shourong Wang; Junchao Qin; Xiyu Zhang; Gang Lu; Hongbin Liu; Haiyang Guo; Ligang Wu; Victoria O Shender; Changshun Shao; Beihua Kong; Zhaojian Liu
Journal:  Nat Commun       Date:  2022-10-21       Impact factor: 17.694

5.  Switched alternative splicing events as attractive features in lung squamous cell carcinoma.

Authors:  Boxue He; Cong Wei; Qidong Cai; Pengfei Zhang; Shuai Shi; Xiong Peng; Zhenyu Zhao; Wei Yin; Guangxu Tu; Weilin Peng; Yongguang Tao; Xiang Wang
Journal:  Cancer Cell Int       Date:  2022-01-05       Impact factor: 5.722

Review 6.  The good, the bad, and the ugly: Evolutionary and pathological aspects of gene dosage alterations.

Authors:  M Felicia Basilicata; Claudia Isabelle Keller Valsecchi
Journal:  PLoS Genet       Date:  2021-12-09       Impact factor: 5.917

Review 7.  Targeting Splicing Factor SRSF6 for Cancer Therapy.

Authors:  Wenting She; Jun Shao; Rong Jia
Journal:  Front Cell Dev Biol       Date:  2021-11-30

8.  Tra2beta-Dependent Regulation of RIO Kinase 3 Splicing During Rift Valley Fever Virus Infection Underscores the Links Between Alternative Splicing and Innate Antiviral Immunity.

Authors:  Luke Adam White; Thomas C Bisom; Hunter L Grimes; Miyuki Hayashi; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  Front Cell Infect Microbiol       Date:  2022-01-19       Impact factor: 5.293

Review 9.  Splicing alterations in healthy aging and disease.

Authors:  Brittany Lynn Angarola; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-02-09       Impact factor: 9.957

Review 10.  SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication.

Authors:  Lulzim Shkreta; Aurélie Delannoy; Anna Salvetti; Benoit Chabot
Journal:  RNA       Date:  2021-07-27       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.